<?xml version="1.0" encoding="UTF-8"?>
<project>
  <language>en</language>
  <availableLanguages>en</availableLanguages>
  <rcn>238393</rcn>
  <id>101042537</id>
  <acronym>RADIOBIO</acronym>
  <teaser>Background and unmet needTargeted radionuclide therapies (TRTs) are a promising modality to treat patients with metastasized cancer. TRTs function via systemic administration of radiolabelled molecules (α- and β-particle emitters) designed to target tumour cells. However...</teaser>
  <objective>Background and unmet need
Targeted radionuclide therapies (TRTs) are a promising modality to treat patients with metastasized cancer. TRTs function via systemic administration of radiolabelled molecules (α- and β-particle emitters) designed to target tumour cells. However, the radiobiological effects of TRTs are poorly understood, and rational design of new modalities based on underlying cellular mechanisms is therefore not possible, resulting in suboptimal treatment strategies. Since most patients with advanced cancer cannot be cured at the moment, it is therefore my ultimate goal to improve TRT.

Aim 
My ERC project aims to identify and quantitate specific radiobiological mechanisms of TRT-radiation effects in vitro and in vivo. 

Objectives
This unique multidisciplinary project will yield critical information on subcellular and intra-tumoural radiopharmaceutical uptake kinetics, DNA damage response kinetics and dose response simulations, and will profoundly increase our knowledge on TRT to push the field forward. I will determine cellular dosimetric parameters for α-TRT and β-TRT, determine effects of subcellular and intra-tumoural localizations of TRT on DNA damage induction and survival, image in vivo TRT efficacy and define effects of treatment heterogeneity to ultimately perform realistic dosimetric simulations in 2D and 3D cancer models. Besides using previously developed techniques, we will develop an innovative new imaging setup for high resolution imaging of TRT by intravital confocal microscopy to image real-time cellular processes of anti-cancer therapies in a living organism.

Expected Outcomes
Outcome of my project will not only increase our fundamental knowledge on TRT and yield a novel imaging modality, but additionally has high potential to contribute to improved treatment strategies and ultimately patient outcomes.</objective>
  <title>Deciphering the radiobiology of targeted radionuclide therapy: from subcellular to intra-tumoural analyses</title>
  <totalCost>1750000</totalCost>
  <ecMaxContribution>1750000</ecMaxContribution>
  <startDate>2022-06-01</startDate>
  <endDate>2027-05-31</endDate>
  <ecSignatureDate>2022-01-28</ecSignatureDate>
  <duration>60</duration>
  <status>SIGNED</status>
  <keywords>Targeted radionuclide therapy, radiobiology, intravital fluorescence microscopy, dosimetric simulations</keywords>
  <identifiers>
    <grantDoi>10.3030/101042537</grantDoi>
  </identifiers>
  <validation>
    <euroSciVoc>false</euroSciVoc>
  </validation>
  <sourceUpdateDate>2025-06-04 11:43:49</sourceUpdateDate>
  <contentCreationDate>2022-07-26 19:55:37</contentCreationDate>
  <contentUpdateDate>2025-06-04 11:43:49</contentUpdateDate>
  <lastUpdateDate>2025-09-19 14:48:38</lastUpdateDate>
  <relations>
    <associations>
      <article source="editorial" type="relatedArticle">
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <rcn>434732</rcn>
        <id>434732-characterising-multilevel-mechanisms-of-targeted-radionuclide-therapy</id>
        <title>Characterising multilevel mechanisms of targeted radionuclide therapy</title>
        <contentUpdateDate>2022-10-17 18:16:00</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/projectDescription</code>
              <title>Project description</title>
              <description>Article: description of linked project written by editorial team</description>
              <displayCode>/Project description</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/editorial</code>
              <title>CORDIS Editorial</title>
              <description>Written by CORDIS</description>
              <displayCode>/CORDIS Editorial</displayCode>
            </category>
          </categories>
        </relations>
      </article>
      <call source="corda" type="relatedMasterCall">
        <rcn>55317</rcn>
        <title>ERC-2021-STG</title>
        <identifier>ERC-2021-STG</identifier>
      </call>
      <call source="corda" type="relatedSubCall">
        <rcn>55317</rcn>
        <title>ERC-2021-STG</title>
        <identifier>ERC-2021-STG</identifier>
      </call>
      <organization netEcContribution="1750000" totalCost="1750000" source="corda" order="1" ecContribution="1750000" terminated="false" sme="false" type="coordinator">
        <availableLanguages>en</availableLanguages>
        <rcn>1906208</rcn>
        <id>999988424</id>
        <vatNumber>NL801427228B01</vatNumber>
        <legalName>ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM</legalName>
        <shortName>ERASMUS MC</shortName>
        <address>
          <street>DR MOLEWATERPLEIN 40</street>
          <city>Rotterdam</city>
          <postalCode>3015  GD</postalCode>
          <country>NL</country>
          <postBox>2040</postBox>
          <url>http://www.erasmusmc.nl</url>
          <geolocation>51.9100181,4.4659629</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/HES</code>
              <title>Higher or Secondary Education Establishments</title>
              <displayCode>/Higher or Secondary Education Establishments</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <rcn>1471673</rcn>
              <nutsCode>NL366</nutsCode>
            </region>
            <region type="relatedRegion">
              <name>Netherlands</name>
              <rcn>391547432</rcn>
              <nutsCode>NL</nutsCode>
              <euCode>NL</euCode>
              <isoCode>NL</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <programme type="relatedTopic" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>705885</rcn>
        <id>HORIZON_ERC-2021-STG</id>
        <code>ERC-2021-STG</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <title>ERC STARTING GRANTS</title>
        <parent>
          <programme>
            <rcn>20300</rcn>
            <code>HORIZON-Topics</code>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/topic</code>
              <title>Topic</title>
              <description>Programme: Part of the Commission work programme implementing legal basis</description>
              <displayCode>/Topic</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <programme type="relatedLegalBasis" source="corda" uniqueProgrammePart="true">
        <availableLanguages>en</availableLanguages>
        <rcn>705727</rcn>
        <id>HORIZON.1.1</id>
        <code>HORIZON.1.1</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <pga>HORIZON.1.1</pga>
        <title>European Research Council (ERC)</title>
        <parent>
          <programme>
            <rcn>705726</rcn>
            <code>HORIZON.1</code>
            <parent>
              <programme>
                <rcn>705725</rcn>
                <code>HORIZON</code>
              </programme>
            </parent>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/legalbasis</code>
              <title>Legal Basis</title>
              <description>Programme: Legal basis for research funding</description>
              <displayCode>/Legal Basis</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <result type="relatedResult" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>1259437</rcn>
        <id>101042537_PSHORIZON</id>
        <title>Periodic Reporting for period 1 - RADIOBIO (Deciphering the radiobiology of targeted radionuclide therapy: from subcellular to intra-tumoural analyses)</title>
        <description>periodic</description>
        <teaser>My ERC project aims to deepen our understanding of targeted radionuclide therapy (TRT) for treating tumours. TRT is a promising cancer treatment that delivers radioactive substances directly to cancer cells, minimizing damage to healthy tissues. However, the effects of TRT can...</teaser>
        <sourceUpdateDate>2025-03-03 18:32:38</sourceUpdateDate>
        <contentUpdateDate>2025-03-03 18:32:38</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/pubsum</code>
              <title>Report Summary</title>
              <description>Result: Publishable summary (FP7 SESAM) and Summary for publication (H2020 SyGMa)</description>
              <displayCode>/Report Summary</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
      <result type="relatedResult" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>1335634</rcn>
        <id>101042537_200706_PUBLIHORIZON</id>
        <title>Evaluating the immune response after targeted radionuclide therapy: towards a correlation between absorbed dose and response</title>
        <details>
          <authors>Justine Perrin, Nina Overdevest, Giulia Tamborino, Julie Nonnekens</authors>
          <journalNumber></journalNumber>
          <journalTitle>International Journal of Radiation Oncology*Biology*Physics</journalTitle>
          <publishedPages></publishedPages>
          <publishedYear>2025</publishedYear>
          <publisher>Elsevier BV</publisher>
        </details>
        <identifiers>
          <issn>0360-3016</issn>
          <doi>10.1016/J.IJROBP.2025.06.3855</doi>
        </identifiers>
        <sourceUpdateDate>2025-07-17 14:47:13</sourceUpdateDate>
        <contentUpdateDate>2025-07-25 11:42:00</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/publication</code>
              <title>Project publication</title>
              <description>Result: Project publications</description>
              <displayCode>/Project publication</displayCode>
            </category>
            <category classification="projectPublication" type="isPublishedAs">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/PEER_REVIEWED_ARTICLE</code>
              <title>Peer reviewed articles</title>
              <displayCode>/Peer reviewed articles</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
      <result type="relatedResult" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>1126799</rcn>
        <id>101042537_1_DELIVHORIZON</id>
        <title>Data management plan</title>
        <description>Data management plan finalized</description>
        <sourceUpdateDate>2024-07-09 08:47:57</sourceUpdateDate>
        <contentUpdateDate>2024-07-08 16:12:02</contentUpdateDate>
        <relations>
          <associations>
            <webLink source="corda" type="projectDeliverable">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <id>4920912530d621dbf170335a7f5f8874</id>
              <physUrl>https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e5ee20dd15&amp;appId=PPGMS</physUrl>
              <defaultLanguage>en</defaultLanguage>
            </webLink>
          </associations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/deliverable</code>
              <title>Project deliverable</title>
              <description>Result: Project deliverables</description>
              <displayCode>/Project deliverable</displayCode>
            </category>
            <category classification="deliverableType" type="isDeliveredAs">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/R</code>
              <title>Documents, reports</title>
              <displayCode>/Documents, reports</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
      <result type="relatedResult" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>1335632</rcn>
        <id>101042537_200707_PUBLIHORIZON</id>
        <title>Establishing In Vitro Dosimetric Models and Dose–Effect Relationships for&lt;sup&gt;177&lt;/sup&gt;Lu-DOTATATE in Neuroendocrine Tumors</title>
        <details>
          <authors>Giulia Tamborino, Pleun Engbers, Tijmen H. de Wolf, Thom G.A. Reuvers, Rob Verhagen, Mark Konijnenberg, Julie Nonnekens</authors>
          <journalNumber></journalNumber>
          <journalTitle>Journal of Nuclear Medicine</journalTitle>
          <publishedPages></publishedPages>
          <publishedYear>2025</publishedYear>
          <publisher>Society of Nuclear Medicine</publisher>
        </details>
        <identifiers>
          <issn>0161-5505</issn>
          <doi>10.2967/JNUMED.125.269470</doi>
        </identifiers>
        <sourceUpdateDate>2025-07-17 14:47:13</sourceUpdateDate>
        <contentUpdateDate>2025-07-25 11:42:00</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/publication</code>
              <title>Project publication</title>
              <description>Result: Project publications</description>
              <displayCode>/Project publication</displayCode>
            </category>
            <category classification="projectPublication" type="isPublishedAs">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/PEER_REVIEWED_ARTICLE</code>
              <title>Peer reviewed articles</title>
              <displayCode>/Peer reviewed articles</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
    </associations>
    <categories>
      <category classification="collection" type="belongsTo">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/project</code>
        <title>Project</title>
        <description>Project factsheets</description>
        <displayCode>/Project</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/23/49/337/1015</code>
        <title>DNA</title>
        <displayCode>/natural sciences/biological sciences/genetics/DNA</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/23/43/251/48354418</code>
        <title>microscopy</title>
        <displayCode>/natural sciences/physical sciences/optics/microscopy</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/21/39/225</code>
        <title>oncology</title>
        <displayCode>/medical and health sciences/clinical medicine/oncology</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/23/53/371/1125</code>
        <title>radiation chemistry</title>
        <displayCode>/natural sciences/chemical sciences/nuclear chemistry/radiation chemistry</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/digitalAgenda</code>
        <title>Digital agenda</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development of digital technologies and the digitisation of the economy and society (known as ‘Digital transition’).</description>
        <displayCode>/Digital agenda</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/cleanAir</code>
        <title>Clean air</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to the clean air policy (National Emission Ceiling Directive) aiming to improve ambient air quality and tackle air pollution, to protect the environment and human health.</description>
        <displayCode>/Clean air</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/ai</code>
        <title>Artificial intelligence</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development and deployment of AI-based technologies and solutions. Projects that develop AI-tools as part of their research method are included</description>
        <displayCode>/Artificial intelligence</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/climate</code>
        <title>Climate action</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to both mitigating climate change (e.g., contributions to the reduction of greenhouse gas emissions) and adapting to climate change by building resilience (e.g., regarding floods, droughts, spatial planning and better governance, adaptation to changing climate in value chains, etc.).</description>
        <displayCode>/Climate action</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/biodiversity</code>
        <title>Biodiversity</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to Europe’s biodiversity’s path to recovery including species protection, ecosystem conservation, and habitat rehabilitation, all essential for resilience in climate adaptation and addressing ecosystem services but also environmental crime and the health-environment connection.</description>
        <displayCode>/Biodiversity</displayCode>
      </category>
      <category classification="projectFundingSchemeCategory" type="relatedProjectFundingSchemeCategory">
        <language>en</language>
        <availableLanguages>en</availableLanguages>
        <code>/HORIZON-ERC</code>
        <title>HORIZON ERC Grants</title>
        <description>HORIZON ERC Grants</description>
        <displayCode>/HORIZON ERC Grants</displayCode>
      </category>
      <category classification="source" type="isProvidedBy">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/corda</code>
        <title>CORDA</title>
        <description>RTD research data warehouse</description>
        <displayCode>/CORDA</displayCode>
      </category>
    </categories>
  </relations>
</project>